|
Symbol Name ID |
Cetn2
centrin 2 MGI:1347085 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Cetn2tm1.1Wbae/Y involves: 129 * FVB/N |
abnormal brain ependyma motile cilium location or orientation | J:211061 |
| abnormal cerebrospinal fluid flow | J:211061 | |
| abnormal olfactory epithelium cilium morphology | J:211061 | |
| abnormal olfactory sensory neuron morphology | J:211061 | |
| normal cellular phenotype | J:211061 | |
| decreased body weight | J:211061 | |
| dilated brain ventricle | J:211061 | |
| dilated lateral ventricle | J:211061 | |
| domed cranium | J:211061 | |
| dysosmia | J:211061 | |
| hydrocephaly | J:211061 | |
| impaired olfaction | J:211061 | |
| premature death | J:211061 | |
| prenatal lethality, incomplete penetrance | J:275959 | |
| normal vision/eye phenotype | J:211061 | |
| weight loss | J:211061 | |
| Cetn2tm1.1Wbae/Y Tg(CAG-EGFP/CETN2)3-4Jgg/0 involves: 129 * BALB/c * C57BL/6 * FVB/N |
no abnormal phenotype detected | J:211061 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|
|
||
Analysis Tools